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Abstract 1 
The Common Sense Model (CSM) is a useful framework for understanding adjustment 2 
(mood and treatment adherence) amongst survivors in the acute phase of stroke (≤three-3 
months). CSM stroke studies have thus far focused on the single outcomes, mood and 4 
medication adherence, neglecting other pertinent aspects of post-stroke recovery (i.e., Health-5 
Related Quality of Life (HRQL) and disability). The purpose of this study was to examine 6 
relationships between baseline illness beliefs and three-month post-stroke HRQL, mood and 7 
disability. A longitudinal observational design was adopted, involving 50 survivors (mean 8 
age=66.9 years, 68% male). The primary outcome, HRQL, was measured using EQ-5D-5L. 9 
The secondary outcome, mood was measured using the Patient Health Questionnaire-9; and 10 
disability, using the Nottingham Extended Activities of Daily Living Scale. A stroke-specific 11 
version of the Illness Perception Questionnaire-Revised measured illness beliefs. Spearman’s 12 
correlations showed that beliefs about the fluctuating effects of stroke (ρ=0.50, p<0.001) and 13 
perceptions of considerable distress at baseline were significantly associated with worse 14 
mood three-months post-stroke (ρ=0.41, p<0.001). Baseline illness beliefs were not 15 
significantly related to three-month post-stroke HRQL or disability. Despite being limited by 16 
a modest sample size, the findings reiterated the need for routine clinical assessment of mood 17 
immediately after stroke, and indicated that simultaneous measurement of timeline-cyclical 18 
beliefs and emotional representations may also be beneficial.  19 
Keywords: Common Sense Model; Illness Beliefs; Stroke; Mood; Depression; 20 
Recovery; Disability; Health-Related Quality of Life. 21 
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Introduction 22 
The Common Sense Model (CSM) suggests that when individuals suffer illness, they 23 
experience a disequilibrium that they become motivated to resolve, and do so by constructing 24 
beliefs about their illness and treatment that guide how they cope with their condition 25 
(Leventhal, Meyer, & Nerenz, 1980). Illness beliefs have five core domains: ‘identity’ – 26 
beliefs about the label of illness; ‘timeline’ – beliefs about illness duration; ‘consequences’ – 27 
beliefs about illness severity/impact; ‘cure/control’ – beliefs about amenability to cure, 28 
prevention or treatment;  and ‘causes’ – beliefs about internal (e.g., genes) and external (e.g., 29 
germ or virus) causes of illness. These have been extended to include: ‘timeline-cyclical’ – 30 
beliefs of an episodic illness; ‘personal control’ and ‘treatment control’  – beliefs about own 31 
ability and that of treatment to manage the illness; ‘illness coherence’ – understanding of the 32 
illness; and ‘emotional representations’ – illness-related distress (Moss-Morris et al., 2002).  33 
Eleven studies have thus far examined relationships between illness beliefs and the 34 
single post-stroke outcomes, mood and medication adherence (Ford, 2007; Johnston et al., 35 
2007; Johnston, Morrison, Macwalter, & Partridge, 1999; Joice, Bonetti, MacWalter, & 36 
Morrison, 2003; Joice, Johnston, & Bonetti, 2002; Klinedinst, Dunbar, & Clark, 2012; 37 
O'Carroll, Chambers, Dennis, Sudlow, & Johnston, 2013; O'Carroll et al., 2011; Phillips, 38 
Diefenbach, Abrams, & Horowitz, 2015; Sjölander, Eriksson, & Glader, 2013; Twiddy, 39 
House, & Jones, 2012). These identified multiple illness beliefs that are significantly 40 
associated with post-stroke mood and medication non-adherence, including perceptions of a 41 
highly symptomatic condition; serious consequences; chronicity; fluctuating effects of stroke; 42 
inability of treatment to manage effects of stroke; poor disease understanding; and stroke-43 
related distress.  44 
This short report examines relationships between illness beliefs and mood, as well as 45 
other important markers of post-stroke recovery (HRQL and disability) that have been 46 
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defined by the International Classification of Functioning (ICF) framework for health and 47 
disability (World Health Organization, 2001), but have mostly been neglected in CSM stroke 48 
studies to date. 49 
 50 
Methods and Materials 51 
We employed a longitudinal observational design, collecting data at baseline (after 52 
study enrolment) and three-months after stroke. Participants were recruited from acute stroke 53 
and rehabilitation wards and outpatient clinics in one hospital in the United Kingdom (UK). 54 
Inclusion criteria were adults (>18 years) with a confirmed diagnosis of acute stroke (within 55 
8-weeks) and sufficient language and cognitive ability to participate. Ethical approval was 56 
granted by the National Research Ethics Service Committee East Midlands – Leicester 57 
(13/EM/0392).  58 
Measures 59 
Our outcomes were defined according to ICF domains (‘impairments’ – problems or 60 
loss in body function; ‘activities’ – performance of a task or action; and ‘participation’ – 61 
involvement in a life situation) (World Health Organization, 2001).  62 
HRQL (ICF Participation) was measured using EQ-5D-5L (Brooks, 1996). Patient 63 
Health Questionnaire-9 (PHQ-9) measured mood (ICF Impairments). We measured disability 64 
(ICF Activities) or ‘instrumental activities of daily living’ (such as shopping, cooking etc.) 65 
using the stroke-specific Nottingham Extended Activities of Daily Living Scale (Nouri & 66 
Lincoln, 1987). Illness beliefs were measured using a version of the IPQ-R adapted to stroke 67 
(Stroke IPQ-R) (Aujla, Vedhara, Walker, & Sprigg, 2018).  68 
After providing written informed consent, we collected socio-demographic; medical 69 
and family history; clinical and lifestyle data. Participants also completed the EQ-5D-5L, 70 
PHQ-9, Nottingham Extended Activities of Daily Living Scale, and Stroke IPQ-R, which 71 
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were repeated at three-months post-stroke. Data were mostly collected via self-report, with 72 
exception of clinician-reported data (e.g. stroke severity) which were abstracted from medical 73 
records. 74 
Statistical Analysis 75 
The primary outcome was three-month post-stroke HRQL –a now prioritised outcome 76 
in acute stroke studies (Deshpande et al., 2011). The secondary outcomes were mood and 77 
disability. We estimated needing 55 participants to detect a correlation of 0.4 between illness 78 
beliefs and markers of post-stroke recovery (e.g., mood), with 80% power, alpha=0.05 and 79 
20% attrition.  80 
Analyses were conducted using STATA 13 (StataCorp LP College Station, TX, USA). 81 
Statistical significance was assessed at the 5% level (p<0.05), and a Bonferroni adjustment 82 
corrected for multiple testing. We examined associations between illness beliefs and post-83 
stroke HRQL, mood and disability using Spearman’s rho (ρ). 84 
 85 
Results 86 
Sample characteristics are summarised in Table 1 and elaborated elsewhere (Aujla, 87 
Walker, Sprigg, & Vedhara, 2018). In brief, 88 of 1085 patients assessed for eligibility over a 88 
12-month period were eligible and approached for participation. The main reasons for non-89 
eligibility were non-stroke diagnosis (N = 249) and stroke onset over 8 weeks before (N = 90 
186). Fifty patients consented, with 16% attrition. Average age was 66.9 years (SD=14.5 91 
years), with 68% males and 98% White-British ethnicity. Around 78% reported a first stroke 92 
and 18% a recurrence. The majority of participants reported few symptoms, but believed their 93 
stroke to be chronic, with fluctuating effects, greatly impacting on their lives, and leading to 94 
considerable distress, and despite having an unsatisfactory understanding (particularly of the 95 
causes) of their stroke, perceived that it was controllable. 96 
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Our analysis used complete cases. Following Bonferroni adjustment, Spearman’s 97 
correlations showed that participants who perceived the effects of their stroke to be episodic 98 
(ρ=0.50, p<0.001) and causing considerable distress (ρ=0.41, p<0.001) at baseline also 99 
reported worse mood three-months after stroke. No significant correlations emerged between 100 
baseline illness beliefs and three-month post-stroke HRQL and disability (see Table 2). 101 
 102 
Discussion 103 
We have shown that mood during the acute phase of recovery after stroke is affected by 104 
maladaptive beliefs about the episodic nature of stroke and stroke-related distress. These 105 
findings were consistent with prior CSM stroke studies, including Ford (2007), Joice et al. 106 
(2003), Klinedinst et al. (2012) and Twiddy et al. (2012). We also uniquely examined 107 
relationships between illness beliefs, HRQL and disability within the first three-months of 108 
stroke. It was surprising that significant associations did not emerge given findings from the 109 
wider CSM literature on physical illnesses (e.g., Damman, Liu, Kaptein, Rosendaal, and 110 
Kloppenburg (2014); Dalbeth et al. (2011); and Spain, Tubridy, Kilpatrick, Adams, and 111 
Holmes (2007)). We suspect that this is likely to relate to our sample. In addition to being 112 
modest in size and inevitably resulting in inadequate statistical power and inflated risk of type 113 
2 error, it also comprised highly functioning survivors of a less severe stroke. An important 114 
limitation of ours and prior CSM stroke studies. 115 
CSM theory argues that illness beliefs form when people experience illness (Leventhal 116 
et al., 1980). This implies that if people do not experience symptoms (i.e., are functioning 117 
well post-illness), the health threat may not be considered enough of a problem for 118 
(mal)adaptive illness beliefs to manifest. In order to gain a more thorough picture of how 119 
illness beliefs relate to these specific aspects of post-stroke recovery, it may instead be better 120 
to examine patients most affected by stroke (i.e., survivors of more severe strokes).  121 
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However, this is a hard group to reach in acute stroke research (Newington & Metcalfe, 122 
2014). The post-stroke impairments that commonly affect these patients (e.g., paralysis, 123 
perceptual difficulties, and impaired cognition) undoubtedly limit their ability to engage with 124 
and provide informed consent for complex studies such as ours. Therefore, it is necessary for 125 
future research to consider ways other than questionnaires to elicit illness beliefs in stroke 126 
survivors with complex needs. One possibility is the ‘Talking Mats’ framework, which 127 
supports people with communication problems (including stroke survivors with aphasia) to 128 
express their views (Murphy, 2000; Murphy, Gray, van Achterberg, Wyke, & Cox, 2010).  129 
In view of these limitations, our findings should be considered exploratory. 130 
Nonetheless, we have shown that the CSM may be a useful framework for understanding 131 
psychological adjustment during the acute phase of stroke, and in particular, that early post-132 
stroke mood may be affected by maladaptive timeline-cyclical beliefs and emotional 133 
representations. These relationships were found even in survivors of a less severe stroke with 134 
little residual disability and mild depressive symptomatology. Therefore, our findings further 135 
emphasise an already recognised need to identify patients with low mood early after stroke 136 
and tie in with the most recent UK stroke clinical guidelines (Intercollegiate Stroke Working 137 
Party, 2016).   138 
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Table 1: Baseline characteristics of the study sample 
 
 
N 
Mean (SD)/Frequency (%), unless otherwise 
stated 
Socio-Demographics 
Age N=50 
66.9 (14.5) 
Sex-Male N=50 
34 (68.0%) 
Ethnic group-White 
 
N=50 
49 (98.0%) 
University or higher education  N=44 
9 (20.5%) 
Employment status  
Unemployed 
Employed full-time 
Employed part-time 
Self-employed 
Retired 
N=46 
6 (13.0%) 
7 (15.2%) 
3 (6.5%) 
5 (10.9%) 
25 (54.4%) 
IMD rank* N=44 
Median=20706.5 (IQR=17158.0) 
IMD decile* N=44 
Median=7 (IQR=6) 
Medical history  
National Institute of Health Stroke Scale 
score¥  
N=44 
Median=2 (IQR=4.5) 
Pre-morbid Modified Rankin Scale 
score¥¥ 
N=48 
0 (0) 
Previous stroke N=46 
36 (78.3) 
Previous TIA N=46 
13 (28.3) 
History of heart attack  N=46 
6 (13.0%) 
History of hypertension N=46 
31 (67.4%) 
History of high cholesterol N=46 
24 (52.2%) 
History of atrial fibrillation N=46 
10 (21.7%) 
History of blood clots  N=46 
5 (10.9%) 
History of angina N=46 
6 (13.0%) 
History of diabetes N=46 
11 (23.9%) 
History of depression N=46 
11 (23.9%) 
History of anxiety N=46 
9 (19.6%) 
Co-morbidities N=49 
34 (69.4%) 
Family history-first degree relative (mother, father, sibling) 
History of stroke N=45 
15 (33.0%) 
History of TIA 
 
N=46 
4 (8.7%) 
Clinical data 
Systolic blood pressure (mm/HG) N=48 
10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symbols and abbreviations: *: Computed using postcode data collected from participants; ¥: High NIHSS scores 
indicate a more severe stroke; ¥¥: High Modified Rankin Scale scores indicate greater disability; ¥¥¥: High 
Barthel Index scores indicate greater independence; ¥¥¥¥: BMI: Body mass index; HDL; High Density 
Lipoprotein; IMD: Index of Multiple Deprivation; IQR: Interquartile range; LDL; Low Density Lipoprotein; 
SD: Standard deviation; TIA: Transient Ischaemic Attack 
 
 
147.6 (33.7) 
Diastolic blood pressure (mm/HG) N=48 
78.6 (20.0) 
Blood glucose (mmol/L) N=37 
Median = 6.6 (IQR=2.8) 
Total cholesterol (mmol/L) N=44 
4.74 (1.30) 
HDL cholesterol (mmol/L) N=40 
Median = 1.3 (IQR=0.6) 
LDL cholesterol (mmol/L) N=38 
Median = 2.7 (IQR=1.9) 
BMI (kg/m2) N=40 
Median = 28 (IQR=9.7) 
Lifestyle  
Current smoking status 
Non/never smoked 
Ex-smoker 
Current smoker 
N=41 
18 (39.1%) 
24 (52.2%) 
4 (8.7%) 
Number smoked daily N=22 
10 (13) 
Units of beer N=41 
0 (7) 
Units of wine N=41 
0 (2) 
Units of spirits N=41 
0 (0) 
30-minutes of exercise x4 times a week N=41 
36 (78.3%) 
Low-fat diet N=41 
24 (52.2%) 
Low-sugar diet N=41 
29 (63.0%) 
Low-salt diet N=41 
29 (64.4%) 
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Table 2. Correlation matrix for baseline illness belief domains and follow-up markers of recovery (N=41) 
 Identit
y 
Timeline 
acute-
chronic 
Timeline
-cyclical 
Consequences Personal 
control 
Treatment 
control 
Illness 
coherenc
e 
Emotional 
representatio
ns 
EQ-5D-5L 
Descriptiv
e System - 
Index 
score 
EQ-5D-5L 
‘Your 
health 
today’ VAS 
score 
Mood Nottingham 
Extended 
ADL 
Identity             
Timeline 
acute-chronic 
0.47 
p<.01 
           
Timeline-
cyclical 
0.62 
p<.001
* 
0.26 
p=0.10 
          
Consequences 0.66 
p<.001
* 
0.45 
p<.01 
0.35 
p<.05 
         
Personal 
control 
0.19 
p=0.23 
-0.19 
p=0.22 
0.12 
p=0.45 
0.06 
p=0.73 
        
Treatment 
control 
-0.04 
p=0.78 
-0.17 
p=0.30 
-0.12 
p=0.47 
-0.00 
p=0.99 
0.30 
p=0.05 
       
Illness 
coherence 
0.17 
p=0.28 
0.00 
p=0.99 
-0.09 
p=0.57 
0.11 
p=0.49 
0.30 
p=0.06 
0.11 
p=0.48 
      
Emotional 
representatio
ns 
0.56 
p<.001
* 
0.27 
p=0.09 
0.51 
p<.001* 
0.63 
p<.001* 
-0.07 
p=0.65 
-0.16 
p=0.30 
-0.00 
p=0.98 
     
EQ-5D-5L 
Descriptive 
System - 
Index score 
-0.27 
p=0.09 
-0.41 
p<.01 
-0.34 
p<.05 
-0.19 
p=0.24 
0.17 
p=0.29 
-0.11 
p=0.49 
0.26 
p=0.10 
-0.26 
p=0.10 
    
EQ-5D-5L 
‘Your health 
today’ VAS 
score 
-0.11 
p=0.49 
-0.22 
p=0.18 
-0.28 
p=0.08 
 
-0.10 
p=0.53 
0.09 
p=0.58 
0.06 
p=0.69 
0.17 
p=0.30 
-0.27 
p=0.09 
0.51 
p<.001* 
   
Mood 0.26 
p=0.10 
0.04 
p=0.80 
0.50 
p<.001* 
0.28 
p=0.07 
-0.06 
p=0.71 
-0.06 
p=0.69 
-0.13 
p=0.43 
0.41 
p<.001* 
-0.21 
p=0.18 
-0.20 
p=0.22 
  
Nottingham 
Extended 
ADL 
-0.18 
p=0.26 
-0.27 
p=0.09 
-0.02 
p=0.90 
-0.04 
p=0.77 
0.02 
p=0.88 
-0.17 
p=0.29 
-0.27 
p=0.09 
-0.03 
p=0.84 
0.49 
p<.01 
0.32 
p<.05 
0.05 
p=0.78 
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Symbols and abbreviations: *: P-value significant at the Bonferroni-adjusted significance level (p<0.002); ADL: Activities of Daily Living; VAS: Visual Analogue Scale 
 
